Analyst Research: Threshold Pharmaceuticals Inc (THLD.OQ)

THLD.OQ on NASDAQ Stock Exchange Capital Market

5.30USD
1 Aug 2013
Price Change (% chg)

$-0.12 (-2.21%)
Prev Close
$5.42
Open
$5.48
Day's High
$5.48
Day's Low
$5.26
Volume
125,670
Avg. Vol
127,854
52-wk High
$9.28
52-wk Low
$3.95

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - THRESHOLD PHARMACEUTICALS, INC. (THLD-O) 1 Aug 2013 Thomson Reuters Stock Report 12 25.00
ValuEngine Detailed Valuation Report for THLD 31 Jul 2013 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Threshold Pharmaceuticals, Inc. 29 Jul 2013 Wright Reports 40 460.00
Threshold Pharmaceuticals 27 Jul 2013 S&P Capital IQ Quantitative Report 5 58.00
THRESHOLD PHARMACEUTICALS INC (THLD) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
Threshold Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
THLD: Due Diligence Review: Forensic Earnings and Valuation 26 Jul 2013 New Constructs, LLC 13 25.00
Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile 22 Jul 2013 GlobalData 28 250.00
THRESHOLD PHARM (THLD) Zacks Company Snapshot 18 Jul 2013 Zacks Investment Research Inc. 1 12.00
 
Name Age Since Current Position

Harold Selick

57 Chief Executive Officer, Director

Stewart Kroll

54 2011 Senior Vice President - Biostatistics and Clinical Operations

Mark Matteucci

59 2007 Senior Vice President - Discovery Research

Joel Fernandes

43 2011 Vice President - Finance, Controller

Tillman Pearce

56 2012 Chief Medical Officer
Search Stocks